[HTML] frontiersin.org

[HTML][HTML] Concurrent genetic alterations and other biomarkers predict treatment efficacy of EGFR-TKIs in EGFR-mutant non-small cell lung cancer: a review

Y Guo, J Song, Y Wang, L Huang, L Sun, J Zhao… - Frontiers in …, 2020 - frontiersin.org
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) greatly improve the
survival and quality of life of non-small cell lung cancer (NSCLC) patients with EGFR …
被引用次数：73 相关文章

[引用][C] Concurrent Genetic Alterations and Other Biomarkers Predict Treatment Efficacy of EGFR-TKIs in EGFR-Mutant Non-Small Cell Lung Cancer: A Review

Y Guo, J Song, Y Wang, L Huang, L Sun… - Frontiers in Oncology …, 2020 - jglobal.jst.go.jp
Concurrent Genetic Alterations and Other Biomarkers Predict Treatment Efficacy of EGFR-TKIs
in EGFR-Mutant Non-Small Cell Lung Cancer: A Review | Article Information | J-GLOBAL Art …

Concurrent Genetic Alterations and Other Biomarkers Predict Treatment Efficacy of EGFR-TKIs in EGFR-Mutant Non-Small Cell Lung Cancer: A Review

Y Guo, J Song, Y Wang, L Huang, L Sun, J Zhao… - Frontiers in …, 2020 - cir.nii.ac.jp
抄録< jats: p> Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)
greatly improve the survival and quality of life of non-small cell lung cancer (NSCLC) …

Concurrent Genetic Alterations and Other Biomarkers Predict Treatment Efficacy of EGFR-TKIs in EGFR-Mutant Non-Small Cell Lung Cancer: A Review

Y Guo, J Song, Y Wang, L Huang, L Sun… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) greatly improve the
survival and quality of life of non-small cell lung cancer (NSCLC) patients with EGFR …

Concurrent Genetic Alterations and Other Biomarkers Predict Treatment Efficacy of EGFR-TKIs in EGFR-Mutant Non-Small Cell Lung Cancer: A Review.

Y Guo, J Song, Y Wang, L Huang, L Sun… - Frontiers in …, 2020 - europepmc.org
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) greatly improve the
survival and quality of life of non-small cell lung cancer (NSCLC) patients with EGFR …
[HTML] nih.gov

[HTML][HTML] Concurrent Genetic Alterations and Other Biomarkers Predict Treatment Efficacy of EGFR-TKIs in EGFR-Mutant Non-Small Cell Lung Cancer: A Review

Y Guo, J Song, Y Wang, L Huang, L Sun… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) greatly improve the
survival and quality of life of non-small cell lung cancer (NSCLC) patients with EGFR …